![]() |
市場調查報告書
商品編碼
2023940
2034年培養肉市場預測-全球原料、產品類型、形態、最終產品、生產技術、應用、最終用戶、通路與區域分析Cultivated Meat Market Forecasts to 2034 - Global Analysis By Source, Product Type, Form, End Product, Production Technology, Application, End User, Distribution Channel, and By Geography |
||||||
根據 Stratistics MRC 預測,全球培養肉市場預計到 2026 年將達到 5 億美元,並在預測期內以 30% 的複合年成長率成長,到 2034 年將達到 41.3 億美元。
培養肉,又稱細胞培養肉或實驗室培育肉,是透過在反應器中直接培養動物細胞而生產的,無需傳統的動物屠宰。這種創新的蛋白質來源不僅具有顯著的環境和倫理優勢,還能複製傳統肉類的口感、質地和營養價值。其市場應用範圍已從漢堡、雞塊和水產品替代品等人類食品擴展到寵物食品等新興領域,並逐漸成為應對全球糧食安全挑戰的變革性解決方案。
全球對永續蛋白質來源的需求日益成長
隨著人們對傳統畜牧業環境影響的擔憂日益加劇,培養肉作為替代方案正受到越來越多的關注。傳統肉類生產會造成溫室氣體排放、土地劣化和水資源消耗,而培養肉依生產方式的不同,可以將這些影響減少高達90%。開發中國家人口成長和中產階級收入提高,對蛋白質的需求空前高漲,而傳統農業已無法永續滿足這項需求。投資者和各國政府已將培養肉視為策略解決方案,既能實現糧食系統脫碳,又能確保蛋白質供應。人造肉在全球多個市場正蓬勃發展,並被用於研究、規模化生產和商業化。
生產成本高昂,大規模生產面臨許多挑戰
儘管技術飛速發展,但以與傳統動物肉相當的價格生產培養肉仍然是其廣泛市場推廣的主要障礙。生產過程需要昂貴的細胞培養基,其中含有生長因子、胺基酸和維生素,以及專用反應器和無菌環境。目前的產量仍然有限,尚未實現能夠降低單位成本的規模經濟。此外,從實驗室規模生產過渡到工業規模生產還面臨複雜的技術挑戰,例如最佳化細胞密度、維持產品品質的穩定性以及開發經濟高效的營養解決方案。這些經濟障礙使得人造肉目前仍局限於高階小眾產品,阻礙了進入更廣泛的市場。
無血清和植物來源培養基配方方面的進展
無動物源細胞培養基研發領域的科學突破為降低生產成本和解決倫理問題提供了重要機會。傳統的細胞培養依賴昂貴的牛,這與培養肉「不虐待動物」的價值提案相違背。利用重組蛋白和植物來源水解物的新配方顯著降低了投入成本,同時消除了動物源成分。這些創新使生產過程更具規模化、成本效益更高,並符合消費者對真正符合倫理的肉類替代品的期望。隨著培養基成本的持續下降,培養肉正日益與傳統肉類競爭,加速其商業化進程,並擴大其在整個蛋白質領域的市場。
監理不確定性和標籤爭議
不同司法管轄區法規結構的不斷變化和不一致,對市場發展和消費者接受度構成重大風險。許多地區仍存在產品分類、安全評估規程和標籤術語等方面的問題懸而未決,這給希望在多個市場推出產品的公司設置了障礙。傳統肉類產業團體的大力遊說導致提案限制在人造肉產品中使用「肉」和「漢堡」等術語,這可能會使消費者感到困惑,並降低行銷效果。這種監管的不確定性增加了合規成本,延誤了產品上市,並帶來了投資風險,即使技術取得了顯著進步,也可能減緩產業成長。
新冠疫情對培養肉市場產生了矛盾的影響,既帶來了挑戰,也帶來了機會。供應鏈中斷和肉類加工廠關閉導致肉類暫時短缺,消費者也因此更加意識到傳統蛋白質來源的脆弱性,並更重視替代生產方式。然而,由於投資者優先考慮緊急醫療需求,疫情也分散了對早期培養肉公司的投資和研發注意力。餐廳關閉也減少了高階培養肉產品的潛在分銷管道。從長遠來看,消費者和政府對更具韌性和分散性的蛋白質生產系統日益成長的興趣,正在為培養肉的廣泛應用創造更有利的長期環境。
在預測期內,「可食用」細分市場預計將佔據最大佔有率。
受全球肉類消費規模龐大且種類繁多的推動,預計在預測期內,「食品」細分市場將佔據最大的市場佔有率。人造牛肉漢堡、雞塊、豬肉香腸和水產品替代品正在開發,作為數十億人每日消費的傳統動物產品的替代品。大型食品服務連鎖店已宣布與培養肉生產商建立合作關係,並表明他們致力於將這些產品納入其主要菜單。消費者接受度調查顯示,消費者越來越願意嘗試培養肉,尤其是與傳統肉品一同展示時。鑑於人類蛋白質消費的巨大市場潛力,以及人造肉帶來的環境和倫理效益,預計該細分市場將在整個預測期內繼續佔據主導地位。
預計在預測期內,寵物食品細分市場將呈現最高的複合年成長率。
在預測期內,寵物食品領域預計將呈現最高的成長率。這反映出消費者日益關注以肉類為主要成分的寵物食品對環境的影響。寵物食品在全球肉類消費中佔據相當大的佔有率,寵物飼主也越來越傾向於尋找符合自身飲食價值觀的永續選擇。培養肉在提供與傳統寵物食品相同營養成分的同時,避免了抗生素、激素以及肉類標籤等令注重健康的寵物飼主擔憂的問題。寵物食品的監管流程通常比人類食品寬鬆,這將加速人造肉進入市場。領先的寵物食品製造商正在投資與培養肉相關的合作項目,加速該領域的擴張。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於大量的創業投資投資、有利的監管政策以及消費者的高度認知。美國已成為全球培養肉創新領域的領導者,為FDA(美國食品藥物管理局)和USDA(美國農業部)認可的細胞培養產品開闢了清晰的市場准入途徑。眾多培養肉Start-Ups已獲得監管部門的核准,並在部分餐廳推出產品,獲得了實際概念驗證(PoC)結果。消費者對替代蛋白的濃厚興趣,加上完善的食品分銷體係以及本土生產商的先發優勢,使北美預計在整個預測期內保持市場領先地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於肉類消費量的成長、對食品安全的擔憂以及政府對替代蛋白研發的支持。新加坡等國率先在全球批准了培養肉的銷售,從而創造了有利的初始市場環境。中國已將培養肉納入國家農業發展規劃,核准到其在減少對進口肉類的依賴以及緩解集約化畜牧業對環境的影響方面的潛力。日本、韓國和以色列也大力投資相關研究。隨著亞太地區龐大的人口擴大採用以肉類為主的飲食結構,培養肉提供了一種永續的解決方案,並正在推動該地區的快速成長。
According to Stratistics MRC, the Global Cultivated Meat Market is accounted for $0.50 billion in 2026 and is expected to reach $4.13 billion by 2034 growing at a CAGR of 30% during the forecast period. Cultivated meat, also known as cell-based or lab-grown meat, is produced by directly culturing animal cells in bioreactors, eliminating the need for traditional animal slaughter. This innovative protein source replicates the taste, texture, and nutritional profile of conventional meat while offering significant environmental and ethical advantages. The market spans human food applications including burgers, nuggets, and seafood alternatives, as well as emerging segments such as cultivated pet food, positioning itself as a transformative solution to global food security challenges.
Rising global demand for sustainable protein sources
Mounting concerns over the environmental footprint of traditional livestock farming are accelerating interest in cultivated meat as a viable alternative. Conventional meat production contributes substantially to greenhouse gas emissions, land degradation, and water consumption, while cultivated meat can reduce these impacts by up to 90% depending on production methods. Population growth and rising middle-class incomes in developing nations are driving unprecedented protein demand that conventional agriculture struggles to meet sustainably. Investors and governments recognize cultivated meat as a strategic solution to decarbonize food systems while ensuring protein availability, creating strong momentum for research, scale-up, and commercialization across multiple global markets.
High production costs and scaling challenges
Despite rapid technological progress, manufacturing cultivated meat at price parity with conventional animal meat remains a significant hurdle for widespread market adoption. The production process requires expensive cell culture media containing growth factors, amino acids, and vitamins, along with specialized bioreactors and sterile environments. Current production volumes remain limited, preventing economies of scale that could reduce per-unit costs. Additionally, the transition from laboratory-scale production to industrial-level manufacturing presents complex engineering challenges, including optimizing cell density, maintaining consistent product quality, and developing cost-effective nutrient solutions. These economic barriers delay broader market entry beyond premium niche offerings.
Advancements in serum-free and plant-based media formulations
Scientific breakthroughs in developing animal-free cell culture media are creating substantial opportunities to reduce production costs and address ethical concerns simultaneously. Traditional cell culture relied on fetal bovine serum, which was expensive and contradicted the cruelty-free value proposition of cultivated meat. New formulations utilizing recombinant proteins and plant-derived hydrolysates are dramatically lowering input costs while eliminating animal-derived components. These innovations make the production process more scalable, cost-effective, and aligned with consumer expectations for truly ethical meat alternatives. As media costs continue declining, cultivated meat becomes increasingly competitive with conventional meat, accelerating commercialization timelines and expanding addressable markets across protein categories.
Regulatory uncertainty and labeling disputes
Evolving and inconsistent regulatory frameworks across different jurisdictions pose significant risks to market development and consumer acceptance. Questions surrounding product classification, safety assessment protocols, and labeling terminology remain unresolved in many regions, creating barriers for companies seeking to launch products across multiple markets. Intense lobbying from traditional meat industry groups has led to proposed legislation restricting the use of terms like "meat" or "burger" for cultivated products, potentially confusing consumers and limiting marketing effectiveness. These regulatory uncertainties increase compliance costs, delay product launches, and create investment risks that could slow industry growth despite strong technological progress.
The COVID-19 pandemic had a paradoxical effect on the cultivated meat market, simultaneously creating challenges and opportunities. Supply chain disruptions and meat processing plant closures led to temporary meat shortages, raising consumer awareness of conventional protein supply vulnerabilities and generating interest in alternative production methods. However, the pandemic also diverted investment capital and research attention away from early-stage cultivated meat companies as investors prioritized immediate healthcare needs. Restaurant closures reduced potential distribution channels for premium cultivated meat products. The lasting impact has been heightened consumer and government interest in resilient, decentralized protein production systems, creating a more favorable long-term environment for cultivated meat adoption.
The Human Food segment is expected to be the largest during the forecast period
The Human Food segment is expected to account for the largest market share during the forecast period, driven by the sheer scale and diversity of meat consumption globally. Cultivated beef burgers, chicken nuggets, pork sausages, and seafood alternatives are being developed to replace conventional animal products consumed daily by billions of people. Major food service chains have announced partnerships with cultivated meat producers, signaling commitment to integrating these products into mainstream menus. Consumer acceptance research indicates growing willingness to try cultivated meat, particularly when presented alongside traditional options. The massive addressable market of human protein consumption, combined with environmental and ethical benefits, ensures this segment dominates market share throughout the forecast timeline.
The Pet Food segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Pet Food segment is predicted to witness the highest growth rate, reflecting growing consumer concern about the environmental impact of meat-based pet diets. Pet food accounts for a significant portion of global meat consumption, with pet owners increasingly seeking sustainable options that align with their own dietary values. Cultivated meat offers nutritional profiles identical to conventional pet food while eliminating antibiotics, hormones, and slaughterhouse by-products that concern health-conscious pet parents. Regulatory pathways for pet food applications are typically less stringent than human food requirements, enabling faster market entry. Major pet food manufacturers are investing in cultivated meat partnerships, accelerating segment expansion.
During the forecast period, the North America region is expected to hold the largest market share, driven by substantial venture capital investment, supportive regulatory progress, and high consumer awareness. The United States has emerged as the global leader in cultivated meat innovation, with the FDA and USDA establishing clear pathways to market for cell-based products. Numerous cultivated meat startups have achieved regulatory approval and launched products in select restaurants, creating real-world proof of concept. Strong consumer interest in alternative proteins, combined with sophisticated food distribution infrastructure and early-mover advantages for domestic producers, positions North America to maintain market leadership throughout the forecast period.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rising meat consumption, food security concerns, and government support for alternative protein research. Countries including Singapore became the first to grant regulatory approval for cultivated meat sales, establishing a favorable early-market environment. China has included cultivated meat in its national agricultural development plans, recognizing its potential to reduce reliance on imported meat and mitigate environmental pressures from intensive livestock farming. Japan, South Korea, and Israel are also making substantial research investments. As Asia Pacific's massive population increasingly adopts meat-centric diets, cultivated meat offers a sustainable path forward, driving the region's rapid growth trajectory.
Key players in the market
Some of the key players in Cultivated Meat Market include Eat Just Inc., Upside Foods, Mosa Meat, Aleph Farms Ltd., Future Meat Technologies, Believer Meats, SuperMeat, Finless Foods Inc., BlueNalu Inc., Wildtype Inc., Shiok Meats Pte Ltd, Vow Group Pty Ltd, Cubiq Foods, Higher Steaks, and CellX.
In January 2026, BlueNalu secured $11 million in new financing to accelerate the commercialization of its seafood products, specifically targeting high-end sushi and fine-dining establishments in the U.S.
In November 2025, Mosa meat partnered with Desmos Capital Partners to secure €30 million in additional capital, aimed at further expanding its Maastricht production facility.
In October 2025, Believer meats received USDA approval for its product label and its 200,000-square-foot production facility in North Carolina, briefly becoming the first large-scale producer cleared for commercial sale in the U.S. before the shutdown.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.